Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Status of gene therapy for cystic fibrosis lung disease
Richard C. Boucher
Richard C. Boucher
Published February 15, 1999
Citation Information: J Clin Invest. 1999;103(4):441-445. https://doi.org/10.1172/JCI6330.
View: Text | PDF
Perspective Article has an altmetric score of 6

Status of gene therapy for cystic fibrosis lung disease

  • Text
  • PDF
Abstract

Authors

Richard C. Boucher

×

Total citations by year

Year: 2024 2019 2018 2013 2011 2007 2004 2003 2002 2001 2000 1999 Total
Citations: 1 1 1 1 3 1 1 1 1 5 4 1 21
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (21)

Title and authors Publication Year
Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy.
Witten J, Raji I, Manan RS, Beyer E, Bartlett S, Tang Y, Ebadi M, Lei J, Nguyen D, Oladimeji F, Jiang AY, MacDonald E, Hu Y, Mughal H, Self A, Collins E, Yan Z, Engelhardt JF, Langer R, Anderson DG
Nature biotechnology 2024
An Intriguing Involvement of Mitochondria in Cystic Fibrosis
Favia, de Bari, Bobba, Atlante
Journal of Clinical Medicine 2019
Physiological study of pulmonary involvement in adults with cystic fibrosis through simulated modeling of different clinical scenarios.
Rodríguez Sousa AA, Barandica Fernández JM, Miller J, Mir-Montejano M
Medical & Biological Engineering & Computing 2018
Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.
Gaspar MC, Couet W, Olivier JC, Pais AA, Sousa JJ
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2013
Gene therapy: light is finally in the tunnel
H Cao, RS Molday, J Hu
Protein & Cell 2011
Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients
K Hida, SK Lai, JS Suk, SY Won, MP Boyle, J Hanes
PloS one 2011
The future of radiology.
Margulis AR
Rambam Maimonides Medical Journal 2011
Vectors for airway gene delivery
PB Davis, MJ Cooper
The AAPS Journal 2007
Glycocalyx Restricts Adenoviral Vector Access to Apical Receptors Expressed on Respiratory Epithelium In Vitro and In Vivo: Role for Tethered Mucins as Barriers to Lumenal Infection
JR Stonebraker, D Wagner, RW Lefensty, K Burns, SJ Gendler, JM Bergelson, RC Boucher, WK O'Neal, RJ Pickles
Journal of virology 2004
Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia
DR Koehler, U Sajjan, YH Chow, B Martin, G Kent, AK Tanswell, C McKerlie, JF Forstner, J Hu
Proceedings of the National Academy of Sciences 2003
Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology
L Zhang, ME Peeples, RC Boucher, PL Collins, RJ Pickles
Journal of virology 2002
Recent advances in cystic fibrosis
IJ Doull
Archives of disease in childhood 2001
Jaagsiekte Sheep Retrovirus Env Protein Stabilizes Retrovirus Vectors against Inactivation by Lung Surfactant, Centrifugation, and Freeze-Thaw Cycling
DA Coil, JH Strickler, SK Rai, AD Miller
Journal of virology 2001
Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose
D T Klink, M C Glick, T F Scanlin
Glycoconjugate Journal 2001
Gene therapy of cystic fibrosis: the glycofection approach
I Fajac, P Briand, M Monsigny
Glycoconjugate Journal 2001
Terminal glycosylation and disease: influence on cancer and cystic fibrosis
T F Scanlin, M C Glick
Glycoconjugate Journal 2001
New insights into the pathogenesis of intestinal dysfunction: secretory diarrhea and cystic fibrosis.
Barrett KE
World Journal of Gastroenterology 2000
Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection.
Zsengellér Z, Otake K, Hossain SA, Berclaz PY, Trapnell BC
Journal of virology 2000
Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer.
Pickles RJ, Fahrner JA, Petrella JM, Boucher RC, Bergelson JM
Journal of virology 2000
Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes.
Ellsworth RE, Jamison DC, Touchman JW, Chissoe SL, Braden Maduro VV, Bouffard GG, Dietrich NL, Beckstrom-Sternberg SM, Iyer LM, Weintraub LA, Cotton M, Courtney L, Edwards J, Maupin R, Ozersky P, Rohlfing T, Wohldmann P, Miner T, Kemp K, Kramer J, Korf I, Pepin K, Antonacci-Fulton L, Fulton RS, Minx P, Hillier LW, Wilson RK, Waterston RH, Miller W, Green ED
Proceedings of the National Academy of Sciences 2000
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
A Nakao, M Fujii, R Matsumura, K Kumano, Y Saito, K Miyazono, I Iwamoto
Journal of Clinical Investigation 1999

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 10 patents
Referenced in 1 clinical guideline sources
48 readers on Mendeley
See more details